Tech Company Financing Transactions
Iambic Therapeutics Funding Round
On 6/19/2024, Iambic Therapeutics raised $50 million in Series B funding from EXOR, Mubadala and Abingworth.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
5627 Oberlin Drive 120
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Our physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Miller
Chief Technical Officer
Fred Manby
Browse more venture capital transactions:
Prev: 6/19/2024: Peak3 venture capital transaction
Next: 6/19/2024: PointFive venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs